We are excited to announce that the Resilix® adherence software application and platform is a finalist for the 2020 CPhI Pharma Awards in the Digital Innovation category!
Improving adherence requires software that is designed specifically with patient needs in mind. As a purpose-built adherence application, Resilix helps brands provide better, more personalized, patient support resulting in higher initiation and adherence, and an improved patient experience. We are proud of the recognition of Resilix and its role in helping patients throughout their treatment journey.
Congratulations to all nominees, and we look forward to grand finale on October 13th.
